Menu
← Oncology Approval Tracker
FDA DECISION ·
Pemetrexed Injection (Actavis) + cisplatin
pemetrexed plus cisplatin · Actavis
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Initial therapy with cisplatin for malignant pleural mesothelioma that is unresectable or unsuitable for curative surgery, using the specified pemetrexed product.
LAMPGEN ANALYSIS
Why it matters
The supplement adds a distinct pleural mesothelioma indication to this product's label.
What research teams should watch
Document diagnosis and surgical candidacy and check product-level preparation instructions.
PRIMARY RECORDS